Publication | Open Access
ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth
27
Citations
39
References
2014
Year
OncologyMedicineImmunologyLung Cancer GrowthBronchial NeoplasmCancer BiologyRadiation OncologyLung CancerCancer ResearchCancer Growth
| Year | Citations | |
|---|---|---|
Page 1
Page 1